MedPath

Effects of Caloric Restriction in Obesity and Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes
Obesity
Interventions
Behavioral: Calorie restriction (25%)
Behavioral: Ad libitum health diet
Registration Number
NCT01930136
Lead Sponsor
Mario Negri Institute for Pharmacological Research
Brief Summary

The study investigates whether a long-term 25% caloric restriction can prevent onset and/or progression of renal function deterioration, retinal involvement and cardiovascular complications in overweight/obese type 2 diabetic patients, trough the amelioration of concomitant metabolic abnormalities such as visceral obesity, insulin resistance, dyslipidemia, hypertension and inflammation.

The main aim of the study is therefore to evaluate the role of calorie restriction (CR) on subjects at risk of nephropathy. Secondary aims are to better understand the relationship between CR and the following aspects: renal disease and its associated metabolic abnormalities, retinopathy and cardiovascular complications, quality of life and treatment cost.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Calorie restriction (25%)Calorie restriction (25%)CR will correspond to a reduction of 25% from the total daily calorie expenditure calculated as Total Daily Energy Expenditure (TDEE) (kcal/d) using the formula from the validated Seven-Day Physical Activity Recall (PAR) Questionnaire (RMR x activity levels).
Ad libitum health dietAd libitum health diet-
Primary Outcome Measures
NameTimeMethod
The percent change in glomerular filtration rate (GFR) at month 6 versus baseline and the rate of GFR decline from month 6 to study endAt baseline, 6, 12 and 24 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Research Center for Rare Diseases

🇮🇹

Ranica, Bergamo, Italy

© Copyright 2025. All Rights Reserved by MedPath